GSK plc recently received approval from the U.S. Food and Drug Administration (FDA) for a prefilled syringe version of SHINGRIX, the company’s vaccine for shingles (herpes zoster). The ...

The U.S. Food and Drug Administration approved a pre-filled syringe version of GSK's blockbuster shingles vaccine Shingrix, ...

Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine ...

Administering Shingrix previously required combining a lyophilised antigen with a liquid adjuvant from two separate vials.

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

GSK (GSK) stock in focus as the U.S. FDA approves a new prefilled syringe presentation of its shingles vaccine, Shingrix.

This image provided by GlaxoSmithKline shows the company's Shingrix vaccine. On Oct. 20, 2017, the Food and Drug Administration approved the vaccine to prevent painful shingles in people aged 50 ...

Recent developments in the health sector highlight diverse changes from drug pricing initiatives by Bristol Myers and Pfizer ...

GlaxoSmithKline agent Hz/su (aka GSK 1437173A), a Herpes zoster (shingles) vaccine candidate, met its primary endpoint in a Phase-III trial, the firm said, and is shaping up to be a potential ...

China's Zhifei will pay GSK about 2.3 billion pounds ($2.9 billion) for the exclusive rights to distribute GSK's shingles vaccine in China, the UK drugmaker said on Thursday, lower than previously ...

GSK GSK0.28%increase; green up pointing triangle expects to further grow sales and earnings after its best-selling shingles vaccine Shingrix and the launch of RSV vaccine Arexvy helped the pharma ...

The newly approved prefilled syringe version of Shingrix is expected to simplify administration and supports efforts to ...